RBC Life Sciences, Inc.
RBCL
$0.0001
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 367.56% | -3,621.21% | -45.54% | 53.19% | 13.57% |
| Total Depreciation and Amortization | -19.27% | -0.93% | -19.07% | -12.27% | 9.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4,563.25% | -1,783.33% | -77.19% | 85.24% | 138.88% |
| Change in Net Operating Assets | -245.15% | -51.64% | 83.16% | 889.92% | -135.56% |
| Cash from Operations | -538.10% | -95.33% | 39.78% | 344.64% | -132.43% |
| Capital Expenditure | 39.21% | 100.00% | 87.62% | 20.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1,801.09% | 100.00% | 87.62% | 36.16% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,810.26% | -7.98% | -7.75% | -8.10% | -8.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,810.26% | -7.98% | -7.75% | -7.89% | 20.59% |
| Foreign Exchange rate Adjustments | 513.94% | 1,036.00% | -63.74% | 2,888.89% | 277.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 264.58% | -103.78% | 44.93% | 189.33% | -157.76% |
